Adicet Bio logo

Adicet Bio Funding & Investors

Adicet Bio, Inc. operates as a clinical-stage bio-pharmaceutical company. The Company designs and develops of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet Bio serves customers worldwide.

adicetbio.com

Total Amount Raised: $358,624,992

Adicet Bio Funding Rounds

  • Series B

    $80,000,000

    Series B Investors

    Pontifax
    Samsung Ventures
    OrbiMed Advisors
    Johnson & Johnson Robotics and Digital Solutions
    Novartis Venture Fund
    Regeneron Pharmaceuticals
  • Series A

    $40,000,000

    Series A Investors

    OrbiMed Advisors
    Nest.Bio Venture
    Quan Capital
    Fidelity Investments
    Rock Springs Capital
    Recharge Capital
  • Post Ipo Equity

    $98,000,000

  • Series A

    $51,000,000

    Series A Investors

    OrbiMed Advisors
    Novartis Venture Fund
    Pontifax
  • Post Ipo Equity

    $50,000,000

  • Series A

    $25,000,000

    Series A Investors

    PureTech Health
  • Series Unknown

    $14,625,000

  • IPO

    Unknown

Funding info provided by Diffbot.